01 5Xyrem
02 4Xywav
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 15
2019 Revenue in Millions : 0
Growth (%) : New Launch
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 1,742
2019 Revenue in Millions : 1,643
Growth (%) : 6
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 535
2020 Revenue in Millions : 15
Growth (%) : 3,407
Main Therapeutic Indication : Sleep
Currency : USD
2021 Revenue in Millions : 1,266
2020 Revenue in Millions : 1,742
Growth (%) : -27
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 958
2021 Revenue in Millions : 535
Growth (%) : 79
Main Therapeutic Indication : Sleep
Currency : USD
2022 Revenue in Millions : 1,020
2021 Revenue in Millions : 1,266
Growth (%) : -19
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 570
2022 Revenue in Millions : 1,020
Growth (%) : -44
Main Therapeutic Indication : Sleep
Currency : USD
2023 Revenue in Millions : 1,273
2022 Revenue in Millions : 958
Growth (%) : 33
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 1,643
2018 Revenue in Millions : 1,405
Growth (%) : 17
